RxDoctor Payments Data

Elvia Ayala Hernandez, MD

General Practice · Aguadilla, PRNPI 1497881189

Payments from drug & device makers

$1,583in general payments, 2019–2025

Across 74 payments — averaging $21.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Sanofi-aventis U.S. LLC$157
  • Eli Lilly Export S.A. Puerto Rico Branch$73
  • Lilly USA, LLC$55
  • Boehringer Ingelheim$49
  • GSK$39
  • plus $20 from 1 others

What the payments were for

  • Food & beverage$1,583100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,583 in reported general payments places this provider in the 90th percentile of 3,586 general practice providers in Puerto Rico.

See all general practice providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$8,118
Medicare patients
18
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol106$118,286
Xigduo XrDapaglifloz Propaned/Metformin34$35,915
JardianceEmpagliflozin29$29,468
XareltoRivaroxaban27$27,557
Soliqua 100-33Insulin Glargine/Lixisenatide25$24,211
SynthroidLevothyroxine Sodium237$22,472
EliquisApixaban19$19,546
TrulicityDulaglutide18$17,693
JanuviaSitagliptin Phosphate22$16,045
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate54$15,923
DiovanValsartan24$12,376
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,312
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$9,055
Spiriva RespimatTiotropium Bromide11$8,908
BrilintaTicagrelor15$8,547

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$1,188$135,888133 claims
Boehringer IngelheimJardiance, Spiriva Respimat$49$38,37740 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$157$27,80651 claims
Lilly USA, LLCTrulicity$55$17,69318 claims
GSKTrelegy Ellipta$39$9,31214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,586 general practice providers in Puerto Rico.

Other general practice in Aguadilla

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →